Unilateral Cutaneous Ureterostomy - Long Term Follow up

Bladder Function Clinical Trial

— ureterostomy  

Official title:

Bladder Function Following Temporary Unilateral Cutaneous Ureterostomy - Long Term Follow up

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00546208
• Other study ID #: SHEBA-07-4838-DZ-CTIL
• Status: Recruiting
• Phase: N/A
• First received: October 17, 2007
• Last updated: March 13, 2008
• Start date: February 2008

Study information

• Verified date: March 2008
• Source: Sheba Medical Center
• Contact: Dorit E Zilberman, MD
• Phone: +97235302231
• Email: dorit.zilberman[@]sheba.health.gov.il
• Is FDA regulated: No
• Health authority: Israel: Israeli Health Ministry Pharmaceutical Administration
• Study type: Observational

Clinical Trial Summary

This observational study is aimed at exploring bladder function following temporary unilateral low loop cutaneous ureterostomy carried out in newborns suffering from severe congenital hydro-ureteronephrosis

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Living patients

• Bilateral functioning kidneys

• Unilateral ureteral cutaneous diversion

Exclusion Criteria:

• Dead patients

• Single kidney

• High percutaneous ureteral diversion (e.g: cutaneous pyelostomies, bilateral cutaneous urinary diversion)

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Bladder Function

Locations

Country	Name	City	State
Israel	The Chaim Sheba Medical Center, Tel Hashomer	Ramat Gan

Sponsors (1)

Lead Sponsor	Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel,